image
Arbutus Biopharma Corporation ABUS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.32
-5.41 %
$ 636 M
Market Cap
-8.74
P/E
BALANCE SHEET
132 M ASSETS
-8.79%
Growth Rates
1Year -8.79%
3Years -13.64%
5Years 4.53%
7Years -8.06%
10Years 1.09%
34.3 M LIABILITIES
-10.53%
Growth Rates
1Year -10.53%
3Years -0.68%
5Years 0.93%
7Years -6.43%
10Years 1.29%
97.4 M EQUITY
-8.16%
Growth Rates
1Year -8.16%
3Years -16.86%
5Years 6.00%
7Years -8.58%
10Years 1.02%
BALANCE SHEET DECOMPOSITION
Balance Sheet Arbutus Biopharma Corporation
image
Current Assets 127 M
Cash & Short-Term Investments 123 M
Receivables 2.41 M
Other Current Assets 2.28 M
Non-Current Assets 4.39 M
Long-Term Investments 0
PP&E 4.36 M
Other Non-Current Assets 34 K
93.10 %3.31 %Total Assets$131.7m
Current Liabilities 15.6 M
Accounts Payable 2.32 M
Short-Term Debt 483 K
Other Current Liabilities 12.8 M
Non-Current Liabilities 18.7 M
Long-Term Debt 0
Other Non-Current Liabilities 18.7 M
6.74 %37.33 %54.52 %Total Liabilities$34.3m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
ASSETS
Cash & Cash Equivalents 36.3 26.3 30.8 109.3 52.3 31.8 36.9 54.3 23.4 166.8 72.2 68.7 47.0 9.0 12.3 23.3 21.5 21.1 4.9 10.5 25.0 35.6 20.5 25.6 2.0 10.9 0.8
Short Term Investments 86.3 99.7 116.1 46.0 71.0 59.0 87.7 72.1 107.1 14.5 40.0 0 0 0 0 0 4.7 0 0 0 0 3.6 17.7 21.9 21.9 8.7 5.7
Receivables 2.4 1.8 1.4 0.9 1.3 1.2 1.4 0.9 0.7 1.4 2.5 0.3 3.5 1.2 3.7 1.3 0.8 1.8 0.6 0.3 1.8 0.4 0.5 2.0 0.8 0.5 0.2
Inventory 0 0 (2.9) (4.4) (3.1) 0 0 0 1 1.1 0 1.0 (2.0) 1 0.2 0 0.1 0.2 1 2 0.3 0 1 1 0.2 1 1
Other Current Assets 2.3 4.2 2.9 8.9 6.2 3.6 3.2 2.5 1.6 1.2 1.8 1.3 0.8 1.2 1.5 0.2 0.2 0.2 0.1 0.4 1.9 1.0 0.2 0.2 0.2 71.2 K 0.3
Total Current Assets 127.3 132.0 151.1 160.7 127.7 93.8 129.2 129.4 132.6 183.9 116.4 70.3 51.2 11.6 17.9 24.8 27.3 23.3 5.5 10.9 28.7 40.1 38.9 49.8 25.2 20.2 6.8
PP&E 4.4 6.1 6.8 8.1 9.3 11.4 10.2 12.2 6.9 3.2 1.8 1.4 1.4 2.2 3.1 2.7 2.1 1.5 0.5 1.0 3.4 4.1 3.7 2.8 2.4 2.9 3.0
Intangible Assets 0 0 0 0 0 0 43.8 58.6 99.4 352.6 0 0 0 0 0 14.5 12.9 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 22.5 24.4 24.4 162.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 6.3 37.4 35.7 0 0 22.2 12.6 12.6 10.1 0 0 0 0 0 0 0 0 0 0 0.6 1.5 2.1 2.2 0.2 0.2 0.2
Other Long Term Assets 34 K 0 0.1 61 K 44 K 0.3 22.2 12.6 12.6 0 0 0 0 0 0 0 1 0 0 0 1.2 0.2 1 15.0 4.9 5.7 6.0
Other Assets 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 1 1 1 1 1 1
Total Assets 131.7 144.4 195.4 204.5 137.1 105.5 227.9 237.2 275.9 712.3 118.2 71.7 52.6 13.7 21.0 41.9 42.3 24.8 6.0 18.5 41.1 50.7 53.2 67.6 32.5 28.8 15.8
LIABILITIES
Accounts Payable 2.3 3.2 3.5 3.2 3.0 2.4 3.2 2.0 3.2 2.6 2.0 1.2 0.8 1.3 0 2.0 0.5 0.3 0.3 1.3 0.9 0 0 0 0 0 0
Short Term Debt 0.5 0.4 0.7 0.8 0.8 0.7 0 0 0 0 0 0 0 0 0 0 0 0.2 83.1 K 49.6 K 0.8 0.4 0.1 0.1 54.6 K 34.3 K 0
Other Current Liabilities 5.2 7.0 20.5 7.3 5.8 4.8 8.0 9.9 7.4 7.1 12.4 11.3 7.0 2.7 6.2 3.4 3.2 1.3 1.3 0.1 9.2 4.1 4.7 2.5 1.9 1.3 0.8
Total Current Liabilities 15.6 22.5 32.9 11.2 9.5 7.8 10.0 11.9 10.6 10.6 14.4 12.5 11.0 6.8 8.1 6.5 4.1 6.5 5.8 2.2 10.9 4.5 4.8 2.6 1.9 1.3 0.8
Long Term Debt 0 8.3 1.8 2.2 2.6 3.0 0 12.0 12.0 0 0 0 0 0 0 0 0 0 65 K 85.5 K 1.0 0.8 0.2 0.2 73.9 K 63.4 K 0
Deferred Tax Income 0 0 0 0 0 (19.0) 12.7 16.9 41.2 146.3 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 0 0
Other Liabilities 18.7 7.6 17.9 21.6 23.0 3.0 3.8 28.1 50.3 7.5 0 0 0 0 0 0 0 0 0 34.7 32.3 2.0 2.6 2.7 0.5 0.5 0.6
Total Liabilities 34.3 38.4 58.6 35.0 35.1 32.8 27.7 54.7 72.9 164.6 30.2 12.5 11.7 8.5 10.3 6.5 4.1 6.5 5.9 37.0 51.6 7.3 7.9 6.1 2.5 1.9 1.4
EQUITY
Common Stock 0 1 349.8 1 318.7 1 286.6 985.9 898.5 879.4 876.1 867.4 834.2 290.0 216.7 239.5 10 333.0 10 333.0 0 0 197.2 154.6 155.2 149.9 138.1 96.1 94.8 68.2 56.9 35.0
Retained Earnings (1 346.6) (1 276.7) (1 203.8) (1 134.3) (1 046.0) (970.1) (805.2) (738.1) (651.1) (267.0) (205.9) (167.0) (230.2) (253.5) (248.9) (211.9) (174.3) (199.8) (167.5) (191.4) (177.1) (142.5) (79.6) (50.6) (38.2) (30.0) (20.5)
Other Accumulative Comprehensive Income/Loss (48.1) (48.4) (50.5) (48.3) (48.2) (48.2) (48.2) (48.2) (49.8) (49.8) (22.3) (15.8) (13.0) (16.1) (15.6) (11.9) (11.6) 0 0 0 0 0 0 0 0 0 0
Total Equity 97.4 106.0 136.9 169.4 102.0 72.7 200.2 182.5 203.0 547.7 88.0 59.2 40.9 5.2 10.7 35.4 38.3 18.4 0.2 (18.5) (10.5) 43.4 45.3 61.5 30.0 26.9 14.4
Total Liabilities and Equity 131.7 144.4 195.4 204.5 137.1 105.5 227.9 237.2 275.9 712.3 118.2 71.7 52.6 13.7 21.0 41.9 42.3 24.8 6.0 18.5 41.1 50.7 53.2 67.6 32.5 28.8 15.8
SHARES OUTSTANDING
Common Shares Outstanding 185.6 166.0 150.9 106.2 75.8 57.1 55.3 54.7 53.1 45.4 21.6 15.3 13.7 11.3 10.3 10.3 8.1 4.8 3.9 7.7 7.7 7.1 6.6 5.1 4.9 2.8 2.2